Cancer Institute A national cancer institute
designated cancer center

Jonathan S. Berek

Publication Details

  • Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.

    Berek JS, Howe C, Lagasse LD, Hacker NF. Gynecol Oncol. 2005; 99 (1): 153-9

    To retrospectively assess the outcome of patients undergoing pelvic exenteration for recurrent or persistence gynecologic malignancy and the clinical features associated with outcome and survival.

    PubMedID: 16054678

Stanford Medicine Resources:

Footer Links: